Advertisement

Topics

Ensysce Biosciences, Inc. Company Profile

21:00 EDT 18th September 2018 | BioPortfolio

Ensysce Biosciences, San Diego, CA, is an integrated drug delivery company for both small and large molecules. To overcome the major problem of non-medical use of opioid products, Ensysce is using its prodrug technology to improve abuse deterrent properties. The BIO-MD™ prodrug abuse deterrent and MPAR™ overdose resistant pain platforms, with worldwide intellectual patent protection, eliminate the ability to abuse opioid products by the non-oral route. This is the fastest growing drug problem in the U.S. and it leads to billions in healthcare costs annually. For additional information about Ensysce Biosciences please visit www.ensysce.com.


News Articles [664 Associated News Articles listed on BioPortfolio]

Ensysce Biosciences to Present Novel TAP Opioid Technology at 7th Annual Gateway Investor Conference September 5, 2018

The promise of protection from opioid abuse. Ensysce Biosciences, Inc., an integrated drug delivery company for both small and large molecules, today announced that D. Lynn Ki...

Ensysce Biosciences to Participate in New Generation Analgesics Symposium at Annual Meeting of the College on Problems of Drug Dependence

Ensysce Biosciences, Inc., an integrated drug delivery company for both small and large molecules, today announced that D. Lynn Kirkpatrick, Ph.D., Chief Executive Officer, will b...

Ensysce Biosciences Receives Multi-Year NIDA Grant to Study and Deliver Opioid Overdose Protection

The promise of a solution to 2 major health crises; opioid abuse and opioid overdose Ensysce Biosciences Inc. today announced receipt of Notice of Award from the N...

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

Companies [362 Associated Companies listed on BioPortfolio]

Ensysce Biosciences, Inc.

Ensysce Biosciences, San Diego, CA, is an integrated drug delivery company for both small and large molecules. To overcome the major problem of non-medical use of opioid products,...

Ensysce Biosciences and Signature Therapeutics

Ensysce, founded in Houston Texas, has an extensive carbon nanotube-related, worldwide intellectual property portfolio, including IP developed at Rice University by Dr. Smalley, a...

Ensysce Biosciences Inc.

Ensysce Biosciences Inc. is focused on the use of carbon nanotubes for therapeutics in the area of cancer treatment. The company owns and has licensed an extensive carbon nanotube...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

More Information about "Ensysce Biosciences, Inc." on BioPortfolio

We have published hundreds of Ensysce Biosciences, Inc. news stories on BioPortfolio along with dozens of Ensysce Biosciences, Inc. Clinical Trials and PubMed Articles about Ensysce Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ensysce Biosciences, Inc. Companies in our database. You can also find out about relevant Ensysce Biosciences, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...


Corporate Database Quicklinks



Searches Linking to this Company Record